Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
228.00    0.00 (0.00%)
Bid:
227.50
Ask:
228.50
Spread: 1.00 (0.44%)
Market Cap: £630.23m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

AGM Trading Update

17 Apr 2009 07:00

RNS Number : 7204Q
Morgan Crucible Co PLC
17 April 2009
 



AGM Trading Update

At today's AGM, Tim Stevenson, OBE, Morgan Crucible's Chairman, will provide the following update.

Group revenues for the first quarter were £255m compared to £178m in the equivalent period last year with strong first year performance from NP Aerospace and the businesses acquired from Carpenter. Excluding the impact of acquisitions, first quarter revenues were up c.11% year-on-year reflecting the benefits of favourable currency translation. In Q1 we have seen, as anticipated, a continuing downward trend in end-market demand meaning that, on a constant currency basis, organic revenues were down 9% compared to Q1 2008.

Of particular note in the period since our last reported results, is the award from the Ministry of Defence of a contract for the Tactical Support Vehicle (TSV) which we announced in early April. This will generate c.£30m of new revenues for NP Aerospace in the latter part of this year and the first half of 2010. 

The refinancing of the Group's banking facilities which mature in March 2010 has progressed well and we are now in the final stages of documentation for the new facility.

Going forward, the ongoing uncertainty in the global economy clearly makes it much more difficult to forecast demand accurately. However, to ensure that we are well prepared for any further deterioration in end market conditions, we are continuing to take decisive action to reduce our operating cost base. Group overall headcount at the end of Q1, excluding acquisitions, has been reduced by over 1,000 people (c.10%) worldwide from its levels of last summer and we stand ready to take further mitigating actions as required.

Our next announcement to shareholders will be our Interim Management Statement in mid May when we will update further on the Group's trading and prospects.

Enquiries:

The Morgan Crucible Company plc  01753 837000

Mark Robertshaw, Chief Executive

Kevin Dangerfield, Chief Financial Officer 

Finsbury Group 020 7251 3801

Mike Smith

Clare Strange

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMBRGDSGGBGGCL
Date   Source Headline
1st Jun 20264:35 pmRNSDirector/PDMR Shareholding
28th May 202610:10 amRNSHolding(s) in Company
26th May 20265:21 pmRNSDirector/PDMR Shareholding
18th May 20262:53 pmRNSHolding(s) in Company
13th May 20265:26 pmRNSHolding(s) in Company
12th May 20262:09 pmRNSDirector/PDMR Shareholding
7th May 20261:19 pmRNSResult of AGM
7th May 20267:00 amRNSCFO Intention to retire
7th May 20267:00 amRNSAGM Trading Update
29th Apr 20264:23 pmRNSDirector/PDMR Shareholding
9th Apr 20263:51 pmRNSHolding(s) in Company
31st Mar 20261:16 pmRNSDirector/PDMR Shareholding
26th Mar 20265:39 pmRNSDirector/PDMR Shareholding
26th Mar 20269:53 amRNSAnnual Financial Report
24th Mar 20262:44 pmRNSDirector/PDMR Shareholding
9th Mar 20269:34 amRNSDirector/PDMR Shareholding
5th Mar 20269:30 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSFull Year Results
23rd Feb 20269:00 amRNSHolding(s) in Company
2nd Feb 20264:12 pmRNSTotal Voting Rights
2nd Feb 20269:30 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202611:57 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 202512:00 pmRNSBlock listing Interim Review
22nd Dec 202512:00 pmRNSBlock listing Interim Review
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.